ATA719279A - Verfahren zur herstellung von neuen halogensubstituierten benzothiopyran-4carbonsaeuren und ihren salzen und alkylester - Google Patents

Verfahren zur herstellung von neuen halogensubstituierten benzothiopyran-4carbonsaeuren und ihren salzen und alkylester

Info

Publication number
ATA719279A
ATA719279A AT0719279A AT719279A ATA719279A AT A719279 A ATA719279 A AT A719279A AT 0719279 A AT0719279 A AT 0719279A AT 719279 A AT719279 A AT 719279A AT A719279 A ATA719279 A AT A719279A
Authority
AT
Austria
Prior art keywords
benzothiopyrane
alkylesters
salts
substituted
producing new
Prior art date
Application number
AT0719279A
Other languages
English (en)
Other versions
AT366680B (de
Inventor
John Belletire
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ATA719279A publication Critical patent/ATA719279A/de
Application granted granted Critical
Publication of AT366680B publication Critical patent/AT366680B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/92Naphthopyrans; Hydrogenated naphthopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT0719279A 1978-11-08 1979-11-08 Verfahren zur herstellung von neuen halogensubstituierten benzopyran- und benzothiopyran-4-carbonsaeuren und ihren salzen und alkylester AT366680B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/959,023 US4210663A (en) 1978-11-08 1978-11-08 Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids

Publications (2)

Publication Number Publication Date
ATA719279A true ATA719279A (de) 1981-09-15
AT366680B AT366680B (de) 1982-04-26

Family

ID=25501572

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0719279A AT366680B (de) 1978-11-08 1979-11-08 Verfahren zur herstellung von neuen halogensubstituierten benzopyran- und benzothiopyran-4-carbonsaeuren und ihren salzen und alkylester

Country Status (16)

Country Link
US (1) US4210663A (de)
EP (1) EP0011426B1 (de)
JP (2) JPS6033433B2 (de)
KR (1) KR830001821B1 (de)
AR (1) AR223195A1 (de)
AT (1) AT366680B (de)
AU (1) AU513399B2 (de)
CA (1) CA1132584A (de)
DE (1) DE2965755D1 (de)
DK (1) DK153947C (de)
ES (1) ES485798A1 (de)
FI (1) FI71139C (de)
IE (1) IE49109B1 (de)
IL (1) IL58656A (de)
PT (1) PT70420A (de)
YU (1) YU41675B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305955A (en) * 1980-10-21 1981-12-15 Pfizer Inc. Carboxylic acid therapeutic agents
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds
US4537920A (en) * 1983-08-18 1985-08-27 Ethyl Corporation 4H-1-benzopyrans and lubricant compositions containing same
US4551542A (en) * 1984-09-26 1985-11-05 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
US4853410A (en) * 1986-01-17 1989-08-01 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
DE69128477T2 (de) * 1990-07-27 1998-07-16 Chugai Seiyaku K.K., Tokio/Tokyo Benzopyranderivat
WO1992014439A1 (en) * 1991-02-18 1992-09-03 Chugai Seiyaku Kabushiki Kaisha Hair growth stimulant
US5407897A (en) * 1993-03-03 1995-04-18 American Cyanamid Company Method for safening herbicides in crops using substituted benzopyran and tetrahydronaphthalene compounds
WO1999043315A1 (fr) * 1998-02-25 1999-09-02 Shionogi & Co., Ltd. Agent therapeutique utilisable en cas de complication de diabetes
US7288279B2 (en) * 2001-12-21 2007-10-30 Michael Foods Of Delaware, Inc. Formulated fried egg product
JP4742215B2 (ja) * 2003-06-23 2011-08-10 Jnc株式会社 クロマン化合物、この化合物を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子
JP5956920B2 (ja) 2012-12-14 2016-07-27 株式会社コガネイ 液体供給装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications

Also Published As

Publication number Publication date
FI793487A (fi) 1980-05-09
YU41675B (en) 1987-12-31
AU513399B2 (en) 1980-11-27
FI71139C (fi) 1986-11-24
KR830001821B1 (ko) 1983-09-12
JPS56103176A (en) 1981-08-18
IL58656A (en) 1983-06-15
FI71139B (fi) 1986-08-14
IE49109B1 (en) 1985-08-07
DE2965755D1 (en) 1983-07-28
AR223195A1 (es) 1981-07-31
YU269779A (en) 1983-02-28
IL58656A0 (en) 1980-02-29
JPS6113716B2 (de) 1986-04-15
PT70420A (de) 1979-12-01
EP0011426B1 (de) 1983-06-22
EP0011426A1 (de) 1980-05-28
IE792136L (en) 1980-05-08
DK153947C (da) 1989-02-20
KR830001273A (ko) 1983-04-30
JPS6033433B2 (ja) 1985-08-02
AT366680B (de) 1982-04-26
DK153947B (da) 1988-09-26
AU5258279A (en) 1980-05-15
ES485798A1 (es) 1980-10-01
DK471079A (da) 1980-05-09
JPS5585582A (en) 1980-06-27
US4210663A (en) 1980-07-01
CA1132584A (en) 1982-09-28

Similar Documents

Publication Publication Date Title
AT374477B (de) Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen
AT375639B (de) Verfahren zur herstellung von neuen carbazolyl-(4)-oxy-propanolamin-derivaten und ihren salzen
ATA136979A (de) Verfahren zur herstellung von neuen 4-pyridon-3- carbonsaeuren und/oder deren derivaten
ATA216884A (de) Verfahren zur herstellung von neuen 3-amino-beta-lactam-1-sulfonsaeuren und ihren salzen
AT373887B (de) Verfahren zur herstellung von neuen n-heterocyclyl-4-piperidinaminen und deren saeureadditionssalzen
AT367025B (de) Verfahren zur herstellung von neuen phenylaethanol-aminen und von salzen hiervon
AT372087B (de) Verfahren zur herstellung von pyrimidonen und ihren salzen
AT368990B (de) Verfahren zur herstellung von neuen n-substituierten omega-aminoalkanoyl-omega-amino- alkansaeuren und ihren salzen
AT366662B (de) Verfahren zur herstellung von neuen 1-aryloxy-3- nitratoalkylamino-2-propanolen und deren saeureadditionssalzen
AT370408B (de) Verfahren zur herstellung von neuen phenylaethanolaminen und von salzen hiervon
ATA719279A (de) Verfahren zur herstellung von neuen halogensubstituierten benzothiopyran-4carbonsaeuren und ihren salzen und alkylester
ATA463779A (de) Verfahren zur herstellung von neuen phenylaethanolaminen und salzen hirvon
ATA78879A (de) Verfahren zur herstellung von neuen w-(2-(nniederalkyl-benzamido)-phenyl)-alkansaeuren und ihren salzen
AT370407B (de) Verfahren zur herstellung von neuen 9-aminoalkyfluorenen und ihren salzen
AT360535B (de) Verfahren zur herstellung von neuen 1-azaxan- thon-3-carbonsaeuren und deren salzen
AT372085B (de) Verfahren zur herstellung von neuen substituierten diphenyl-imidazolyl-methanen und von deren salzen
ATA193279A (de) Verfahren zur herstellung von neuen n-phenylaminosaeuren
AT367052B (de) Verfahren zur herstellung von neuen modifizierten azulminsaeuren
AT374468B (de) Verfahren zur herstellung von neuen substituierten chinazolinen und ihren salzen
AT373897B (de) Verfahren zur herstellung von neuen aralkylund aryloxyalkylphosphonaten
AT356122B (de) Verfahren zur herstellung von neuen pyridazinonderivaten und ihren salzen mit saeuren
AT364377B (de) Verfahren zur herstellung von neuen n-mercaptoalkanoyl-4-aminocarbonyloxyprolinen und ihren salzen
ATA690279A (de) Verfahren zur herstellung von neuen 2-amino-1phenylcyclopentanolestern in form der betaisomeren und deren salzen
AT357156B (de) Verfahren zur herstellung von neuen thio- xanthen-verbindungen und ihren salzen
ATA214383A (de) Verfahren zur herstellung von neuen substituierten chinazolinen und ihren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee